Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.
复制标题
DOI:
10.1016/j.juro.2009.02.032
复制
发表时间:
2009-06
期刊:
影响因子:
--
通讯作者:
MIST Investigators
中科院分区:
文献类型:
--
作者:
Helfand BT;Mongiu AK;Roehrborn CG;Donnell RF;Bruskewitz R;Kaplan SA;Kusek JW;Coombs L;McVary KT;MIST Investigators
The primary responsibility of Institutional Review Boards (IRBs) is to protect human research subjects and therefore ensure that studies are conducted in accordance with a standard set of ethical principles. A number of studies have compared the responses from IRBs in multicenter clinical trials involving medical therapies. To date, none have been conducted in trials investigating surgical interventions. The intent of this study was to investigate the consistency of the recommendations issued from one institutional IRB to another in the Minimally Invasive Surgical Therapies (MIST) for benign prostatic hyperplasia (BPH), a multicenter trial with a uniform consent and study protocol. We obtained the IRB responses from six of the seven participating institutions after the initial submission of the MIST study protocol and classified the responses. We then re-distributed the approved protocols to an IRB at another participating institution and analyzed their review of these protocols. We found that both the number and types of responses required for IRB approval of an identical study protocol varied significantly among the participating institutions. We also found that IRB responses were inconsistent in the second review, although all protocols were ultimately approved. We conclude that the current system of local IRB review in the context of a multicenter surgical trial is inefficient in the review process and may not provide expertise in overseeing surgical trials. Based on these results, a central surgical IRB may be needed to improve of the ethical review process in multicenter trials.